Navigation Links
Transdermal Pain Management to 2016: Products, Markets, Forecasts and Opportunities
Date:9/19/2012

NEW YORK, Sept. 19, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Transdermal Pain Management to 2016: Products, Markets, Forecasts and Opportunities

http://www.reportlinker.com/p0970178/Transdermal-Pain-Management-to-2016-Products-Markets-Forecasts-and-Opportunities.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication

As life expectancy in the developed world increases and populations age, the incidence and associated morbidity of chronic and acute pain is increasing and placing a higher level of emphasis on pain management as a quality-of-life issue for patients and their families. Responding to this trend, drug developers are increasingly turning to transdermal formulations of pain management drugs. Because it has the potential to improve drug therapy compliance, transdermal delivery addresses a key healthcare issue – one that is particularly problematic in aging populations and developing economies. Currently approved transdermal pain products include narcotics, NSAIDs, and topical anesthetics. These patches and gels will encounter competition from development-stage transdermal formulations for a number of pain medications presently being marketed in oral or parenteral form. Several of these development programs involve international partnerships designed to take advantage of perceived opportunities in regional markets.

Highlights • Analyzes and evaluates the global market opportunity for transdermal pain management and assesses the probable impact of evolving regulatory, economic and demand factors

• Assesses transdermal products approved or in development for the delivery of therapeutic pain management drugs

• Provides detailed descriptions of pain management treatment segments, market factors, and business strategies

• Forecasts transdermal pain management product demand to 2016 by geographic region and product segment

• Profiles sector companies, their product development activities, supply chain partners, business strategies, and collaboration partners

Executive Summary

Scope and Definitions

The Current Pain Management Picture

Unmet Needs in Pain Management

The Opportunity for Transdermal Delivery of Pain Drugs

The Pain Management Market Opportunity

Evolution in Pain Management Guidelines

Regional Factors in Pain Management Practice

Pain Management Demand Drivers

Competitive Landscape

Factors Limiting Growth

Transdermal Drug Delivery Dynamics

Transdermal Pain Management Patches

Pain Patch Technology & Architectures

Transdermal Patch Manufacturing and Packaging

Patch Economics

Passive vs Active Delivery Systems

Transdermal Pain Management Gels

Transdermal Formulations

IP and Proprietary Technology

Limitations of Topical Gels

Transdermal Pain Management Product Assessments and Market Prospects

FDA Approved Transdermal Pain Management Products

Narcotic

NSAIDs

Local Anesthetic

Non-FDA Approved Commercial Transdermal Pain Management Products

Narcotic

NSAIDs

Local Anesthetic

Development-Stage Transdermal Pain Management Products

Narcotic

NSAID

Other Drug Classes

Transdermal Pain Management Market Factors

Regional Regulations

Clinical Trials

Quality and Reliability

Indications Prescribing Guidelines and Off-Label Prescribing

Managed Care and Payor Initiatives

Rx-to-OTC Switching

Skin Patch Revenue Models

Market Forecasts

Forecasts by Region

Forecasts by Drug Class

Forecasts by Delivery Form Factor

Market Share Data

Market Participant Profiles

To order this report:Drug_and_Medication Industry: Transdermal Pain Management to 2016: Products, Markets, Forecasts and Opportunities

Contact
Nicolas Bombourg
Reportlinker
Email: nicolasbombourg@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Transdermal Hormone Replacement: Products, Players, Markets and Forecasts
2. Purdue Pharma L.P. To Present Analysis Of Butrans® (buprenorphine) Transdermal System CIII Clinical Data At American Pain Society Annual Meeting
3. Valeant Pharmaceuticals Announces Management Change
4. ConvaTec, A Leader In Antimicrobial Dressings And Infection Management, To Host Live International Webcast On Minimizing Risk Of Wound Infections
5. Roche Selects Thomson Reuters to Transform the Management of Its Intellectual Property Assets
6. MyEvaluations.com Launches New Medical Education Management Solutions That Meet ACGME NAS Accreditation Requirements
7. Saint Vincent Health System Selects onFocus Healthcare for Enterprise Performance Management
8. Global Airway Management Devices Industry
9. Accelrys ELN Advances Innovation Lifecycle Management with Enhanced Biology Capabilities from Screening to Preclinical Development
10. Selfhelp Community Services and FEGS Health & Human Services Launch New Care Management Company: SinglePoint Care Network to Coordinate Care for Seniors & Others With Chronic Medical Conditions in Managed Long Term Care Market
11. Actinium Pharmaceuticals Strengthens Management Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... -- Eli Lilly and Company (NYSE: LLY ) today announced ... vitamin regimen patent would not presently be infringed by Actavis ... , Italy and Spain ... dextrose solution.  --> --> ... held that Lilly,s patent would be indirectly infringed by Actavis ...
(Date:2/12/2016)... , 12 februari 2016 ... een toonaangevende leverancier van productie en ontwikkeling ... industrieën, kondigt vandaag een uitbreiding aan van ... haar locatie in Charleston, SC ... geleid tot meerdere recente investeringen. ...
(Date:2/12/2016)... Maharashtra, February 12, 2016 ... report titled Chronic Inflammation Global Clinical Trials Review, ... of the global clinical trials landscape along with ... by Region, Country (G7 & E7), Trial Status, ... and reviews top companies involved and enlists all ...
Breaking Medicine Technology:
(Date:2/12/2016)... VA (PRWEB) , ... February 12, 2016 , ... ... Feb. 29, 2016 — 1:30 p.m. – 3:00 p.m. EST, http://www.fdanews.com/fixeddosecombination ... in the life cycle of pharmaceutical products, garnering increased attention from all stakeholders ...
(Date:2/12/2016)... ... ... Coco Libre, the maker of coconut water beverages with a purpose, is ... Coco Libre will offer musicians and celebrities the company’s signature Organic Coconut Water, a ... suite, held this year at the W Hollywood Hotel, has become a pre-show “must” ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... (WaaS), today announced the integration of Clarity Intelligence Platform (CIP) into Cielo®, a ... offer real-time business intelligence (BI) to their small and medium business (SMB) clients. ...
(Date:2/12/2016)... ... 2016 , ... AssureVest Insurance Group, a locally owned insurance firm with offices ... raise funds earmarked to purchase computers and software for Mrs. Harrison’s 2nd and 3rd ... in a low-income area and has more than 60 2nd and 3rd graders with ...
(Date:2/12/2016)... , ... February 12, 2016 , ... Erlanger Agency has ... greater Columbus, OH area. The latest campaign focuses on the fight against breast cancer, ... are now being accepted here . , Carmen is a loving single mother ...
Breaking Medicine News(10 mins):